David R. Raleigh, Ph.D. - Related publications

2010 Pathology University of Chicago, Chicago, IL 
Cell Biology, Molecular Biology, Bioinformatics Biology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Eickstaedt JB, Fancher W, Havighurst T, Xu YG. Lack of documentation of lymph node examination in patients with squamous cell carcinoma of the lower lip. Archives of Dermatological Research. PMID 34562138 DOI: 10.1007/s00403-021-02281-4   
2021 Chen J, Mai H, Chen H, Zhou B, Hou J, Jiang DK. Pan-Cancer Analysis Identified as a Potential Biomarker for Multiple Tumor Types. Frontiers in Molecular Biosciences. 8: 693651. PMID 34490347 DOI: 10.3389/fmolb.2021.693651   
2021 Chan D, Kaplan J, Gordon G, Desai J. Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult Cases. Current Oncology (Toronto, Ont.). 28: 3659-3667. PMID 34590610 DOI: 10.3390/curroncol28050312   
2021 Zou J, Yang X, Duan J, Wang J, Yang Z, Luo D, Liu L, Chen J, Nie J. A Case Report of Targeted Therapy with Anlotinib in a Patient with Advanced Breast Metaplastic Carcinoma. Oncotargets and Therapy. 14: 4599-4607. PMID 34475766 DOI: 10.2147/OTT.S318645   
2021 Akeret K, Vasella F, Staartjes VE, Velz J, Müller T, Neidert MC, Weller M, Regli L, Serra C, Krayenbühl N. Anatomical phenotyping and staging of brain tumours. Brain : a Journal of Neurology. PMID 34554211 DOI: 10.1093/brain/awab352   
2021 Kostakoglu L, Mattiello F, Martelli M, Sehn LH, Belada D, Ghiggi C, Chua N, González-Barca E, Hong X, Pinto A, Shi Y, Tatsumi Y, Bolen C, Knapp A, Sellam G, et al. Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study. Haematologica. PMID 34407602 DOI: 10.3324/haematol.2021.278663   
2021 Synnott NC, Poeta ML, Costantini M, Pfeiffer RM, Li M, Golubeva Y, Lawrence S, Mutreja K, Amoreo C, Dabrowska M, Simone G, Pescarmona E, Lenz P, Olanich M, Duggan M, et al. Characterizing the tumor microenvironment in rare renal cancer histological types. The Journal of Pathology. Clinical Research. PMID 34618413 DOI: 10.1002/cjp2.241   
2021 Ait Ssi S, Chraa D, El Azhary K, Sahraoui S, Olive D, Badou A. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades. Frontiers in Immunology. 12: 685213. PMID 34539626 DOI: 10.3389/fimmu.2021.685213   
2021 Yuan C, Zhao X, Wangmo D, Alshareef D, Gates TJ, Subramanian S. Tumor models to assess immune response and tumor-microbiome interactions in colorectal cancer. Pharmacology & Therapeutics. 107981. PMID 34480964 DOI: 10.1016/j.pharmthera.2021.107981   
2021 Ono Y, Cates JMM, Gonzalez RS. Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma? Pathology, Research and Practice. 226: 153608. PMID 34530256 DOI: 10.1016/j.prp.2021.153608   
2021 El Helali A, Kwok GST, Tse KY. Adjuvant and post-surgical treatment in non-epithelial ovarian cancer. Best Practice & Research. Clinical Obstetrics & Gynaecology. PMID 34493450 DOI: 10.1016/j.bpobgyn.2021.06.001   
2021 Gül D, Habtemichael N, Dietrich D, Dietrich J, Gößwein D, Khamis A, Deuss E, Künzel J, Schneider G, Strieth S, Stauber RH. Identification of cytokeratin24 as a tumor suppressor for the management of head and neck cancer. Biological Chemistry. PMID 34450690 DOI: 10.1515/hsz-2021-0287   
2021 He F, Xia Y, Ling X. Diagnosis and Individualized Treatment of Three Primary Malignant Tumors: A Case Report. Breast Cancer (Dove Medical Press). 13: 519-527. PMID 34526817 DOI: 10.2147/BCTT.S321390   
2021 Muraishi N, Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Okubo S, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, et al. Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment. Internal Medicine (Tokyo, Japan). PMID 34511564 DOI: 10.2169/internalmedicine.7589-21   
2021 Xia Y, Huang S, Wang Y, Lei D, Wang Y, Yang H, Gao Y, Liu P. Prognostication of Primary Tumor Location in Early-Stage Nodal Diffuse Large B-Cell Lymphoma: An Analysis of the SEER Database. Cancers. 13. PMID 34439110 DOI: 10.3390/cancers13163954   
2021 Lan Y, Zhao E, Zhang X, Zhu X, Wan L, A S, Ping Y, Wang Y. Prognostic impact of a lymphocyte activation-associated gene signature in GBM based on transcriptome analysis. Peerj. 9: e12070. PMID 34527446 DOI: 10.7717/peerj.12070   
2021 Thompson R, Landry CS. Multiple endocrine neoplasia 1: a broad overview. Therapeutic Advances in Chronic Disease. 12: 20406223211035288. PMID 34413971 DOI: 10.1177/20406223211035288   
2021 Takigawa K, Hata N, Sangatsuda Y, Suzuki SO, Sirozu N, Hatae R, Akagi Y, Iwaki T, Nagata S, Mizoguchi M. Intraventricular mucin-producing glioblastoma arising in the septum pellucidum at the frontal horn of the lateral ventricle: A case report. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 34382251 DOI: 10.1111/neup.12759   
2021 Chang Y, Wang Y, Li B, Lu X, Wang R, Li H, Yan B, Gu A, Wang W, Huang A, Wu S, Li R. Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer. Frontiers in Genetics. 12: 722078. PMID 34616428 DOI: 10.3389/fgene.2021.722078   
2021 Ohara F, Harada Y, Tanikawa Y, Narita M, Kagami Y, Hiraga J. [A rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma with multiple solitary extramedullary plasmacytomas of the liver]. [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology. 62: 727-732. PMID 34349055 DOI: 10.11406/rinketsu.62.727   
2021 Wei B, Yu M, Yao J, Jiang M, An J, Yang J, Lin J, Zhao Y, Zhu Y. Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma. Frontiers in Immunology. 12: 657951. PMID 34531849 DOI: 10.3389/fimmu.2021.657951   
2021 Liu H, Tang C, Yang Y. Identification of Nephrogenic Therapeutic Biomarkers of Wilms Tumor Using Machine Learning. Journal of Oncology. 2021: 6471169. PMID 34422051 DOI: 10.1155/2021/6471169   
2021 Pachva MC, Lai H, Jia A, Rouleau M, Sorensen PH. Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment. Frontiers in Cell and Developmental Biology. 9: 726205. PMID 34604225 DOI: 10.3389/fcell.2021.726205   
2021 Zhang N, Shao F, Jia W. Upregulation of microfibrillar-associated protein 2 is closely associated with tumor angiogenesis and poor prognosis in hepatocellular carcinoma. Oncology Letters. 22: 739. PMID 34466151 DOI: 10.3892/ol.2021.13000   
2021 Ravindra N, Rao S, Arivazhagan A, Santosh V. Maternal embryonal leucine zipper kinase immunoreactivity in atypical teratoid/rhabdoid tumors: a study of 50 cases. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. PMID 34611764 DOI: 10.1007/s00381-021-05335-0   
2021 Gao R, Zhao S, Aishanjiang K, Cai H, Wei T, Zhang Y, Liu Z, Zhou J, Han B, Wang J, Ding H, Liu Y, Xu X, Yu Z, Gu J. Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data. Journal of Hematology & Oncology. 14: 154. PMID 34565412 DOI: 10.1186/s13045-021-01167-2   
2021 Kapur P, Gao M, Zhong H, Chintalapati S, Mitui M, Barnes SD, Zhou Q, Miyata J, Carrillo D, Malladi VS, Rakheja D, Pedrosa I, Xu L, Kinch L, Brugarolas J. Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 34538873 DOI: 10.1038/s41379-021-00896-6   
2021 Maravelia P, Silva DN, Rovesti G, Chrobok M, Stål P, Lu YC, Pasetto A. Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy. Cancers. 13. PMID 34503144 DOI: 10.3390/cancers13174334   
2021 Boldrini L, Faviana P, Galli L, Paolieri F, Erba PA, Bardi M. Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA Database. Genes. 12. PMID 34573332 DOI: 10.3390/genes12091350   
2021 Lebok P, Schütt K, Kluth M, Witzel I, Wölber L, Paluchowski P, Terracciano L, Wilke C, Heilenkötter U, Müller V, Schmalfeldt B, Simon R, Sauter G, Von Leffern I, Krech T, et al. High mitochondrial content is associated with breast cancer aggressiveness. Molecular and Clinical Oncology. 15: 203. PMID 34462659 DOI: 10.3892/mco.2021.2365   
2021 Cheng L, Creasy T, Pilataxi F, Greenlees L, Vence L, Sridhar S, Streicher K. Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma. Cancer Immunology, Immunotherapy : Cii. PMID 34623465 DOI: 10.1007/s00262-021-03065-5   
2021 Young RH, Wong A, Stall JN. Yolk Sac Tumor of the Ovary: A Report of 150 Cases and Review of the Literature. The American Journal of Surgical Pathology. PMID 34469331 DOI: 10.1097/PAS.0000000000001793   
2021 Bourgouin PP, Wrobel MM, Mercaldo N, Murphy MC, Leppelmann KS, Levesque VM, Muniappan A, Silverman SG, Shepard JO, Shyn PB, Fintelmann FJ. Comparison of Percutaneous Image-Guided Microwave and Cryoablation for Sarcoma Lung Metastases: 10-Year Experience. Ajr. American Journal of Roentgenology. PMID 34612679 DOI: 10.2214/AJR.21.26551   
2021 Ingle A, Reddy S, Reddy VK. Omental Solitary Fibrous Tumor: A Rare Tumor at Rare Site. Journal of Laboratory Physicians. 13: 283-285. PMID 34602796 DOI: 10.1055/s-0041-1731942   
2021 Luo T, Ding K, Ji J, Zhang X, Yang X, Chen A, Huang B, Zhang D, Wang J, Li X. Cytoskeleton-associated protein 4 (CKAP4) promotes malignant progression of human gliomas through inhibition of the Hippo signaling pathway. Journal of Neuro-Oncology. PMID 34476666 DOI: 10.1007/s11060-021-03831-6   
2021 van der Sijde F, Azmani Z, Besselink MG, Bonsing BA, de Groot JWB, Groot Koerkamp B, Haberkorn BCM, Homs MYV, van IJcken WFJ, Janssen QP, Lolkema MP, Luelmo SAC, Mekenkamp LJM, Mustafa DAM, van Schaik RHN, et al. Circulating mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX. Therapeutic Advances in Medical Oncology. 13: 17588359211033704. PMID 34422118 DOI: 10.1177/17588359211033704   
2021 Yim SY, Lee JS. An Overview of the Genomic Characterization of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 8: 1077-1088. PMID 34522690 DOI: 10.2147/JHC.S270533   
2021 Hu LF, Yang X, Lan HR, Fang XL, Chen XY, Jin KT. Preclinical tumor organoid models in personalized cancer therapy: Not Everyone Fits the Mold. Experimental Cell Research. 112858. PMID 34600901 DOI: 10.1016/j.yexcr.2021.112858   
2021 Chen X, Li C, Li Y, Wu S, Liu W, Lin T, Li M, Weng Y, Lin W, Qiu S. Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma. Frontiers in Molecular Biosciences. 8: 727481. PMID 34604305 DOI: 10.3389/fmolb.2021.727481   
2021 Jeong J, Kim DK, Park JH, Park DJ, Lee HJ, Yang HK, Kong SH, Jung K. Tumor-Infiltrating Neutrophils and Non-Classical Monocytes May Be Potential Therapeutic Targets for HER2 Gastric Cancer. Immune Network. 21: e31. PMID 34522444 DOI: 10.4110/in.2021.21.e31   
2021 Couper MR, Eldredge JA, Kirby M, Kirby C, Moore D, Hammond P, Manton N, Glynn A, Couper RT. Paediatric Gastrointestinal, Hepatic and Pancreatic Inflammatory Myofibroblastic Tumours, A Single Centre Experience. Journal of Pediatric Gastroenterology and Nutrition. PMID 34596604 DOI: 10.1097/MPG.0000000000003311   
2021 Akbarzadeh-Jahromi M, Aslani FS, Raeisi H, Momtahan M, Taheri N. Comparison of Frozen and Permanent Section Diagnosis in Ovarian Neoplasms: Analysis of Factors Affecting Accuracy. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. PMID 34456277 DOI: 10.1097/PGP.0000000000000821   
2021 Kobayashi H, Gieniec KA, Ng JQ, Goyne J, Lannagan TRM, Thomas EM, Radford G, Wang T, Suzuki N, Ichinose M, Wright JA, Vrbanac L, Burt AD, Takahashi M, Enomoto A, et al. Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma. Journal of Visualized Experiments : Jove. PMID 34542536 DOI: 10.3791/62630   
2021 Yoshii Y, Okazaki S, Takeda M. Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid Biopsy. Life (Basel, Switzerland). 11. PMID 34440540 DOI: 10.3390/life11080796   
2021 Knight BJ, Wood GA, Foster RA, Coomber BL. Beclin-1 is a novel predictive biomarker for canine cutaneous and subcutaneous mast cell tumors. Veterinary Pathology. 3009858211042578. PMID 34521293 DOI: 10.1177/03009858211042578   
2021 You B, Freyer G, Gonzalez-Martin A, Lheureux S, McNeish I, Penson RT, Pignata S, Pujade-Lauraine E. The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas. Cancer Treatment Reviews. 100: 102294. PMID 34564042 DOI: 10.1016/j.ctrv.2021.102294   
2021 Alhalabi KT, Stichel D, Sievers P, Peterziel H, Sommerkamp AC, Sturm D, Wittmann A, Sill M, Jäger N, Beck P, Pajtler KW, Snuderl M, Jour G, Delorenzo M, Martin AM, et al. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum. Acta Neuropathologica. PMID 34417833 DOI: 10.1007/s00401-021-02354-8   
2021 Guo R, Zhang D, Zhang C, Yang Y, Liu H, Yang Y, Lin J. Immunotoxin IHP25-BT with low immunogenicity and off-target toxicity inhibits the growth and metastasis of trastuzumab-resistant tumor cells. International Journal of Pharmaceutics. 121081. PMID 34506924 DOI: 10.1016/j.ijpharm.2021.121081   
2021 Ma F, Vayalil J, Lee G, Wang Y, Peng G. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment. Journal For Immunotherapy of Cancer. 9. PMID 34642246 DOI: 10.1136/jitc-2021-003217   
2021 Somasegar S, Hoppenot C, Kuchta K, Sereika A, Khandekar J, Rodriguez G, Moore E, Hurteau J, Vogel TJ. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers. Gynecologic Oncology. PMID 34511240 DOI: 10.1016/j.ygyno.2021.08.027